Clinical Trial Update: Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating contrast-enhanced ultrasound to assess response to chemoembolization in patients with liver cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: john eisenbrey | Conditions: Liver Neoplasms | Phase 2 | Status: RECRUITING